Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations (Translational Neurodegeneration, (2022), 11, 1, (24), 10.1186/s40035-022-00299-w)

the Lewy Body Dementias Clinical Trials Workgroup from the Lewy Body Dementias Professional Interest Area - Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART)+

doi:10.1186/s40035-022-00306-0

Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations (Translational Neurodegeneration, (2022), 11, 1, (24), 10.1186/s40035-022-00299-w)

the Lewy Body Dementias Clinical Trials Workgroup from the Lewy Body Dementias Professional Interest Area - Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART)+

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Following publication of the original article [1], the authors identified some errors in the Additional files 1–5. The original article [1] has been corrected.

Original language	English (US)
Article number	29
Journal	Translational Neurodegeneration
Volume	11
Issue number	1
DOIs	https://doi.org/10.1186/s40035-022-00306-0
State	Published - Dec 2022

ASJC Scopus subject areas

Clinical Neurology
Cognitive Neuroscience
Cellular and Molecular Neuroscience

Access to Document

10.1186/s40035-022-00306-0

Cite this

the Lewy Body Dementias Clinical Trials Workgroup from the Lewy Body Dementias Professional Interest Area - Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART)+ (2022). Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations (Translational Neurodegeneration, (2022), 11, 1, (24), 10.1186/s40035-022-00299-w). Translational Neurodegeneration, 11(1), Article 29. https://doi.org/10.1186/s40035-022-00306-0

Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations (Translational Neurodegeneration, (2022), 11, 1, (24), 10.1186/s40035-022-00299-w). / the Lewy Body Dementias Clinical Trials Workgroup from the Lewy Body Dementias Professional Interest Area - Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART)+.
In: Translational Neurodegeneration, Vol. 11, No. 1, 29, 12.2022.

Research output: Contribution to journal › Comment/debate › peer-review

the Lewy Body Dementias Clinical Trials Workgroup from the Lewy Body Dementias Professional Interest Area - Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART)+ 2022, 'Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations (Translational Neurodegeneration, (2022), 11, 1, (24), 10.1186/s40035-022-00299-w)', Translational Neurodegeneration, vol. 11, no. 1, 29. https://doi.org/10.1186/s40035-022-00306-0

the Lewy Body Dementias Clinical Trials Workgroup from the Lewy Body Dementias Professional Interest Area - Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART)+. Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations (Translational Neurodegeneration, (2022), 11, 1, (24), 10.1186/s40035-022-00299-w). Translational Neurodegeneration. 2022 Dec;11(1):29. doi: 10.1186/s40035-022-00306-0

the Lewy Body Dementias Clinical Trials Workgroup from the Lewy Body Dementias Professional Interest Area - Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART)+. / Correction : Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations (Translational Neurodegeneration, (2022), 11, 1, (24), 10.1186/s40035-022-00299-w). In: Translational Neurodegeneration. 2022 ; Vol. 11, No. 1.

@article{4a89dc287af44b419fb04b0393a823c5,

title = "Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations (Translational Neurodegeneration, (2022), 11, 1, (24), 10.1186/s40035-022-00299-w)",

abstract = "Following publication of the original article [1], the authors identified some errors in the Additional files 1–5. The original article [1] has been corrected.",

author = "\{the Lewy Body Dementias Clinical Trials Workgroup from the Lewy Body Dementias Professional Interest Area - Alzheimer{\textquoteright}s Association International Society to Advance Alzheimer{\textquoteright}s Research and Treatment (ISTAART)+\} and Federico Rodriguez-Porcel and Wyman-Chick, \{Kathryn A.\} and \{Abdelnour Ruiz\}, Carla and Toledo, \{Jon B.\} and Daniel Ferreira and Prabitha Urwyler and Weil, \{Rimona S.\} and Joseph Kane and Andrea Pilotto and Arvid Rongve and Bradley Boeve and Taylor, \{John Paul\} and Ian McKeith and Dag Aarsland and Lewis, \{Simon J.G.\}",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

month = dec,

doi = "10.1186/s40035-022-00306-0",

language = "English (US)",

volume = "11",

journal = "Translational Neurodegeneration",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Correction

T2 - Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations (Translational Neurodegeneration, (2022), 11, 1, (24), 10.1186/s40035-022-00299-w)

AU - the Lewy Body Dementias Clinical Trials Workgroup from the Lewy Body Dementias Professional Interest Area - Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART)+

AU - Rodriguez-Porcel, Federico

AU - Wyman-Chick, Kathryn A.

AU - Abdelnour Ruiz, Carla

AU - Toledo, Jon B.

AU - Ferreira, Daniel

AU - Urwyler, Prabitha

AU - Weil, Rimona S.

AU - Kane, Joseph

AU - Pilotto, Andrea

AU - Rongve, Arvid

AU - Boeve, Bradley

AU - Taylor, John Paul

AU - McKeith, Ian

AU - Aarsland, Dag

AU - Lewis, Simon J.G.

PY - 2022/12

Y1 - 2022/12

N2 - Following publication of the original article [1], the authors identified some errors in the Additional files 1–5. The original article [1] has been corrected.

AB - Following publication of the original article [1], the authors identified some errors in the Additional files 1–5. The original article [1] has been corrected.

UR - https://www.scopus.com/pages/publications/85131867063

UR - https://www.scopus.com/inward/citedby.url?scp=85131867063&partnerID=8YFLogxK

U2 - 10.1186/s40035-022-00306-0

DO - 10.1186/s40035-022-00306-0

M3 - Comment/debate

AN - SCOPUS:85131867063

VL - 11

JO - Translational Neurodegeneration

JF - Translational Neurodegeneration

IS - 1

M1 - 29

ER -

Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations (Translational Neurodegeneration, (2022), 11, 1, (24), 10.1186/s40035-022-00299-w)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this